Rubeosis Iridis
📧 Sign up to get email alerts when something new happens for Rubeosis Iridis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis [Phase 3]
Phase 3 trial evaluating intravitreal aflibercept vs ranibizumab for rubeosis iridis in glaucoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma [NA]
This entry reports the completion of a clinical trial evaluating ranibizumab (Lucentis) for patients with neovascular glaucoma and rubeosis …
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery [Phase 1]
Phase 1 trial evaluating ranibizumab to treat rubeosis iridis in diabetics before cataract surgery, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2011-11-29Clinical Trial Update: Intraocular Bevacizumab (Avastin) for Rubeosis Iridis [Phase 4]
Phase 4 trial evaluating intravitreal bevacizumab (Avastin) for rubeosis iridis associated with glaucoma; the study is completed.
-
CLINICAL_TRIALS trial_result · 2007-05-07Clinical Trial Update: Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.). [Phase 2]
Phase 2 open-label trial of anecortave acetate sterile suspension (15 mg) for treatment of rubeosis iridis related to severe diabetic retino…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.